3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
7
Uterine Cervical Neoplasms
5
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Retinoblastoma
1
Radiation Injuries
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Genital Neoplasms, Female
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Surveys and Questionnaires
6
Surgical Procedures, Operative
2
Drug Therapy
2
trastuzumab deruxtecan
1
Watchful Waiting
1
Sentinel Lymph Node Biopsy
1
Radiotherapy
1
RNA
1
Quality of Life
1
Psychiatric Rehabilitation
1
Patient Reported Outcome Measures
1
Observation
1
Multimodal Imaging
1
Molecular Diagnostic Techniques
1
Interviews as Topic
1
Indocyanine Green
1
Immunotherapy
1
Immunohistochemistry
1
Hysterectomy
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
DNA
1
Circulating Tumor DNA
1
CA-125 Antigen
1
Buthionine Sulfoximine
1
Brachytherapy
1
Blood Specimen Collection
1
Biopsy
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Vulvar Neoplasms
×
Brachytherapy
×
Clear all
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled